These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 350389
1. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma. Presant CA, Ratkin G, Klahr C. Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389 [No Abstract] [Full Text] [Related]
2. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma. Budman DR, Schulman P, Vinciguerra V, Degnan T. Cancer Treat Rep; 1981 Apr; 65(5-6):535. PubMed ID: 7237477 [No Abstract] [Full Text] [Related]
3. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma. Taylor SG, Desai SA, DeWys WD. Cancer Treat Rep; 1978 Aug; 62(8):1203-5. PubMed ID: 356978 [Abstract] [Full Text] [Related]
4. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer. Haller DG, Woolley PV, Macdonald JS, Smith LF, Schein PS. Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394 [Abstract] [Full Text] [Related]
5. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil. Kessinger MA, Foley JF, Lemon HM. Cancer Clin Trials; 1979 Apr; 2(4):317-9. PubMed ID: 394867 [Abstract] [Full Text] [Related]
6. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer. Buroker T, Wojtaszak B, Dindogru A, DeMattia M, Baker L, Groth C, Vaitkevicius VK. Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398 [Abstract] [Full Text] [Related]
7. 5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase II study. Biran H, Sulkes A, Biran S. Cancer Treat Rep; 1981 May; 65(9-10):924-5. PubMed ID: 7273031 [No Abstract] [Full Text] [Related]
15. A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer. Schutt AJ, Hahn RG, Reitemeier RJ, Moertel CG. Cancer Res; 1973 Oct; 33(10):2218-20. PubMed ID: 4741927 [No Abstract] [Full Text] [Related]
16. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma. O'Connell MJ, Moertel CG, Rubin J, Schutt AJ, Creagan ET. Cancer Treat Rep; 1980 Oct; 64(2-3):311-3. PubMed ID: 7190870 [Abstract] [Full Text] [Related]
17. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer. Cantrell JE, Brunet R, Lagarde C, Schein PS, Smith FP. Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972 [Abstract] [Full Text] [Related]
18. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine]. Roth A, Kolarić K. Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141 [No Abstract] [Full Text] [Related]
20. Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study. Davis S, Park YK. Cancer Treat Rep; 1978 Oct; 62(10):1557-9. PubMed ID: 709556 [Abstract] [Full Text] [Related] Page: [Next] [New Search]